Remove 2016 Remove FDA Approval Remove Screening Hits
article thumbnail

A PAINful itch

Molecular Design

I've included some photos to break up the text a bit and these are from a 2016 visit to the north of Vietnam. The distinction between Type 1 and and Type 2 behaviors is an important and useful one to make from the perspective of drug discovery scientists who are making decisions as to which screening hits to take forward.